Similar articles

• [Cyclosporin in autoimmune diseases].

  Follath F, Fontana A, Leumann E, Michel BA, Miescher PA, Schreier M, Schroeder M, Wenk M. Follath F, et al. Schweiz Med Wochenschr. 1994 Jul 12;124(27-28):1232-9. Schweiz Med Wochenschr. 1994. PMID: 8052828 Review. German.
• The place of cyclosporine A in the treatment of connective tissue diseases.

  Miescher PA, Favre H, Mihatsch MJ, Chatelanat F, Huang YP, Zubler R. Miescher PA, et al. Transplant Proc. 1988 Jun;20(3 Suppl 4):224-37. Transplant Proc. 1988. PMID: 3381275 No abstract available.
• Immunologic and clinical effects of cytotoxic drugs used in the treatment of rheumatoid arthritis and systemic lupus erythematosus.

  Fox DA, McCune WJ. Fox DA, et al. Concepts Immunopathol. 1989;7:20-78. Concepts Immunopathol. 1989. PMID: 2676180 Review. No abstract available.
• Renal function in patients with autoimmune diseases treated with cyclosporine.

  von Graffenried B, Harrison WB. von Graffenried B, et al. Transplant Proc. 1985 Aug;17(4 Suppl 1):215-31. Transplant Proc. 1985. PMID: 3839609 No abstract available.
• [Prospects of the use of cyclosporin A in rheumatic diseases].

  Nasonov EL, Shtutman VZ, Nasonova VA. Nasonov EL, et al. Klin Med (Mosk). 1994;72(5):12-9. Klin Med (Mosk). 1994. PMID: 7853807 Review. Russian. No abstract available.